{
    "id": 27023,
    "fullName": "CD79B Y196S",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "CD79B Y196S lies within the ITAM domain of the Cd79b protein (UniProt.org). Y196S has been identified in the scientific literature (PMID: 27915469, PMID: 28856744, PMID: 28619981, PMID: 29629945, PMID: 26752547), but has not been biochemically characterized and therefore, its effect on Cd79b protein function is unknown (PubMed, Oct 2019).",
            "references": [
                {
                    "id": 10036,
                    "pubMedId": 27915469,
                    "title": "MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27915469"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 10035,
                    "pubMedId": 28619981,
                    "title": "Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28619981"
                },
                {
                    "id": 12384,
                    "pubMedId": 26752547,
                    "title": "Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26752547"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 12383,
                    "pubMedId": 29629945,
                    "title": "Clonal Evolution in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29629945"
                },
                {
                    "id": 10037,
                    "pubMedId": 28856744,
                    "title": "Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28856744"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 974,
        "geneSymbol": "CD79B",
        "terms": [
            "CD79B",
            "AGM6",
            "B29",
            "IGB"
        ]
    },
    "variant": "Y196S",
    "createDate": "10/03/2017",
    "updateDate": "10/06/2019",
    "referenceTranscriptCoordinates": {
        "id": 108776,
        "transcript": "NM_000626",
        "gDna": "chr17:g.63929438T>G",
        "cDna": "c.587A>C",
        "protein": "p.Y196S",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 12111,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, a patient with primary central nervous system lymphoma harboring both CD79B Y196S and MYD88 L265P demonstrated stable disease when treated with Imbruvica (ibrutinib) (PMID: 28619981).",
            "molecularProfile": {
                "id": 28416,
                "profileName": "CD79B Y196S MYD88 L265P"
            },
            "therapy": {
                "id": 768,
                "therapyName": "Ibrutinib",
                "synonyms": null
            },
            "indication": {
                "id": 3234,
                "name": "central nervous system lymphoma",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 10035,
                    "pubMedId": 28619981,
                    "title": "Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28619981"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28402,
            "profileName": "CD79B Y196S",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 28416,
            "profileName": "CD79B Y196S MYD88 L265P",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 108776,
            "transcript": "NM_000626",
            "gDna": "chr17:g.63929438T>G",
            "cDna": "c.587A>C",
            "protein": "p.Y196S",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}